
The Milan System and Other Aspects of Salivary Gland Cytology
![]() | William C. Faquin, MD, PhD Director, Head & Neck Pathology Massachusetts General Hospital Boston, Massachusetts |
Salivary gland cytology represents one of the most challenging areas of cytopathology due to the diverse array of both benign and malignant tumors, many with overlapping microscopic features. This session will familiarize the audience with key cytologic features of many of the more common as well as challenging salivary gland tumors. An emphasis will be placed on the avoidance of certain diagnostic pitfalls, and the application of selected ancillary tests (cytochemical, immunologic, and molecular markers) will be reviewed. Finally, an overview of the newly proposed Milan System for Reporting Salivary Gland Cytopathology will be presented.
Target Audience
This educational activity is designed for pathologists, cytopathologists, cytotechnologists, students and other members of the cytopathology community.
Learning Objectives
- Recognize key cytologic features of selected salivary gland tumors
- Avoid common pitfalls in the cytologic diagnosis of salivary gland tumors
- Utilize immunocytochemical and molecular markers for salivary gland tumors
- Be familiar with the newly proposed Milan System for Reporting Salivary Gland Cytopathology
William C. Faquin, MD, PhD
Director, Head & Neck Pathology
Massachusetts General Hospital
Boston, Massachusetts
Current ACCME guidelines state that participants in CME activities should be made aware of any affiliation or financial interest that may affect the speaker’s presentation(s). Therefore, it is the policy of the ASC to insure balance, independence, objectivity, and scientific rigor in all its educational programs. All planning individuals participating in any ASC Educational Activity are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. Click here for a complete list.
Presenter
William C. Faquin, MD, PhD
Disclosure
The presenter has no conflicts of interest or financial relationships to disclose.
ACCREDITATION AND DESIGNATION STATEMENTS
Continuing Medical Education (CME) Statement
The American Society of Cytopathology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Cytopathology designates this enduring educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
American Board of Pathology Maintenance of Certification (MOC)
This product can help fulfill the CME requirements and Self-Assessment Modules (SAMs) mandated by the American Board of Pathology Maintenance of Certification (MOC) process. Earn up to 2.0 SAM Credit Hours.
Continuing Medical Laboratory Education (CMLE)
The ASC designates this activity for a maximum of 2.0 Continuing Medical Laboratory Education (CMLE) credit hours for non-physicians. The CMLE credit hours meet the continuing education requirements for the ASCP Board of Registry Certification Maintenance Program. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Cytotechnologists with Licenses in Florida and California
This program is approved for 2 continuing education credits in the State of Florida and 1 in the State of California. The credit on each link is good for three years from the live presentation date.
Available Credit
- 2.00 AMA PRA Category 1 Credit™
- 1.00 California Credits
- 2.00 CMLE
- 2.00 Florida Credits
- 2.00 MOC II
- 2.00 Participant